Literature DB >> 22847167

Diabetes: Does aspirin increase the risk of major bleeds?

Carlo Patrono.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22847167     DOI： 10.1038/nrcardio.2012.113

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  8 in total

Review 1.  Antiplatelet agents for the treatment and prevention of atherothrombosis.

Authors:  Carlo Patrono; Felicita Andreotti; Harald Arnesen; Lina Badimon; Colin Baigent; Jean-Philippe Collet; Raffaele De Caterina; Dietrich Gulba; Kurt Huber; Steen Husted; Steen Dalby Kristensen; João Morais; Franz-Josef Neumann; Lars Hvilsted Rasmussen; Agneta Siegbahn; Philippe-Gabriel Steg; Robert F Storey; Frans Van de Werf; Freek Verheugt
Journal:  Eur Heart J       Date:  2011-10-20       Impact factor: 29.983

2.  Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Authors:  Michael Pignone; Mark J Alberts; John A Colwell; Mary Cushman; Silvio E Inzucchi; Debabrata Mukherjee; Robert S Rosenson; Craig D Williams; Peter W Wilson; M Sue Kirkman
Journal:  Circulation       Date:  2010-05-27       Impact factor: 29.690

Review 3.  Low-dose aspirin for the prevention of atherothrombosis.

Authors:  Carlo Patrono; Luis A García Rodríguez; Raffaele Landolfi; Colin Baigent
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

4.  The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes.

Authors:  B Rocca; F Santilli; D Pitocco; L Mucci; G Petrucci; E Vitacolonna; S Lattanzio; D Mattoscio; F Zaccardi; R Liani; N Vazzana; A Del Ponte; E Ferrante; F Martini; C Cardillo; R Morosetti; M Mirabella; G Ghirlanda; G Davì; C Patrono
Journal:  J Thromb Haemost       Date:  2012-07       Impact factor: 5.824

5.  Association of aspirin use with major bleeding in patients with and without diabetes.

Authors:  Giorgia De Berardis; Giuseppe Lucisano; Antonio D'Ettorre; Fabio Pellegrini; Vito Lepore; Gianni Tognoni; Antonio Nicolucci
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

6.  Risk of upper gastrointestinal bleeding with low-dose acetylsalicylic acid alone and in combination with clopidogrel and other medications.

Authors:  Luis A García Rodríguez; Kueiyu Joshua Lin; Sonia Hernández-Díaz; Saga Johansson
Journal:  Circulation       Date:  2011-02-28       Impact factor: 29.690

7.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

8.  Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins.

Authors:  Giorgia De Berardis; Michele Sacco; Virgilio Evangelista; Alessandro Filippi; Carlo B Giorda; Gianni Tognoni; Umberto Valentini; Antonio Nicolucci
Journal:  Trials       Date:  2007-08-28       Impact factor: 2.279
  8 in total
  1 in total

Review 1.  A systematic review of aspirin in primary prevention: is it time for a new approach?

Authors:  Carlos Brotons; Robert Benamouzig; Krzysztof J Filipiak; Volker Limmroth; Claudio Borghi
Journal:  Am J Cardiovasc Drugs       Date:  2015-04       Impact factor: 3.571
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.